Cargando…
In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2(R1441G) mutant mouse model of Parkinson's disease
BACKGROUND: Leucine‐rich repeat kinase 2 (LRRK2) mutation is a common genetic risk factor of Parkinson's disease (PD). Presynaptic dysfunction is an early pathogenic event associated with dopamine (DA) dysregulation in striatum of the brain. DA uptake activity of DA uptake transporter (DAT) aff...
Autores principales: | Ho, Philip Wing‐Lok, Li, Lingfei, Liu, Hui‐Fang, Choi, Zoe Yuen‐Kiu, Chang, Eunice Eun Seo, Pang, Shirley Yin‐Yu, Malki, Yasine, Leung, Chi‐Ting, Kung, Michelle Hiu‐Wai, Ramsden, David Boyer, Ho, Shu‐Leong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927849/ https://www.ncbi.nlm.nih.gov/pubmed/36624932 http://dx.doi.org/10.1002/brb3.2886 |
Ejemplares similares
-
Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression
por: Li, Lingfei, et al.
Publicado: (2022) -
LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
por: Liu, Hui-Fang, et al.
Publicado: (2014) -
Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2(R1441G) mice
por: Liu, Huifang, et al.
Publicado: (2020) -
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
por: Chang, Eunice Eun Seo, et al.
Publicado: (2022) -
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)